TABLE 3:
Health Care Utilization and Costs
No Chronic Opioid Therapy; Enrollment for 2+ y (n = 76,584) | Chronic Opioid Therapy for 1–3 y; Enrollment ≥4 y (n = 2371) | Persistent Chronic Opioid Therapy ≥4 y (n = 132) | P | |
---|---|---|---|---|
Health care utilization | ||||
IBD hospitalizations, % | ||||
0 | 74.4 | 36.9 | 15.2 | <0.001 |
1–2 | 15.5 | 42 | 43.7 | |
3–4 | 4.7 | 10.4 | 16.1 | |
5+ | 5.4 | 10.6 | 25 | |
≥1 IBD surgeries | 7.8 | 26.4 | 46.2 | <0.001 |
Outpatient visits, mean | 12.3 | 16.3 | 26.4 | <0.001 |
≥1 ED visits | 48.5 | 88.1 | 96.2 | <0.001 |
Polypharmacy,a mean | 3.9 | 4.2 | 5.9 | <0.001 |
No. prescriptions, % | ||||
0–4 | 65 | 61.7 | 28 | |
5+ | 35 | 38.3 | 72 | <0.001 |
Health care costs | ||||
High-cost patients,b % | 9.2 | 13.9 | 28.8 | <0.001 |
Total costs per year (SD), $ | 20,473 (40,105) | 28,139 (30,342) | 44,766 (42,823) | <0.001 |
Hospitalization cost (SD), $ | 6351 (7041) | 7028 (7996) | 5284 (3597) | <0.001 |
aExcluding IBD medications.
bHigh-cost patients defined as annual health care costs >$50,000.